GliaNeurosciencePeer-reviewed journal article
Müller glial Kir4.1 channel Dysfunction in APOE4-KI model of Alzheimer's disease
Surabhi D. AbhyankariD, Yucheng XiaoiD, Neha S. MahajaniD, Qianyi LuoiD, Theodore CumminsiD, Adrian L. OblakiD, Bruce T. LambiD, Timothy W. CorsoniD, Ashay Dilip BhatwadekariD
Abstract
Alzheimers disease (AD), particularly late-onset AD (LOAD), affects millions worldwide, with the apolipoprotein {varepsilon}4 (APOE4) allele being a significant genetic risk factor. Retinal abnormalities are a hallmark of LOAD, and our recent study demonstrated significant age-related retinal impairments in APOE4-knock-in (KI) mice, highlighting that retinal impairments occur before the onset of cognitive decline in these mice. Muller cells (MCs), key retinal glia, are vital for retinal health, and their dysfunction may contribute to retinal impairments seen in AD. MCs maintain potassium balance via specialized inwardly rectifying K+ channels 4.1 (Kir4.1). This study posits that Kir4.1 channels will be impaired in APOE4-KI, resulting in MC dysfunction. Additionally, we demonstrate that MC dysfunction in APOE4-KI stems from alterations in mitochondrial dynamics and oxidative stress. Kir4.1 expression and function were studied using immunofluorescence and through the whole-cell voltage clamp, respectively. In parallel, rat Muller cells (rMC-1) were used to create an in vitro model for further mechanistic studies. Mitoquinol (MitoQ) was used to evaluate its potential to mitigate APOE4-induced deficits. APOE4 retinas and APOE4-transfected rMC-1 significantly reduced Kir4.1 expression, K+ buffering capacity, and increased mitochondrial damage. APOE4-transfected rMC-1 showed reduced mitochondrial membrane potential ({Delta}{Psi}m) and increased mitochondrial reactive oxygen species (ROS). MitoQ treatment significantly reduced mitochondrial ROS and restored Kir4.1 expression in APOE4-expressing cells. Our results demonstrate that APOE4 causes mitochondrial dysfunction and MC impairment, which may contribute to retinal pathology in AD. MitoQ restored mitochondrial health and Kir4.1 expression in APOE4-expressing rMC-1, suggesting targeting mitochondria may offer a promising therapeutic strategy for AD. Main PointsO_LIAPOE4 impairs Muller cell health by reducing Kir4.1 expression and buffering. C_LIO_LIAPOE4 causes mitochondrial dysfunction with decreased {Delta}{Psi}m and increased ROS. C_LIO_LIMitoQ restores Kir4.1 expression and reduces ROS in APOE4-transfected cells. C_LI
- Citations
- 3
- FWCI
- 4.51
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cholesterol and matrisome pathways dysregulated in human APOE ε4 glia
Julia TCW, Shuang Liang, … Alison Goate·bioRxiv·Jul 25, 2019
- Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microglia
Jasmin S. Revanna, Karl A. Wessendorf-Rodriguez, … Fred H. Gage·bioRxiv·May 13, 2026
- Long-term Dietary Fat Intervention Affects Retinal Health in APOE Mice
Surabhi D. Abhyankar, Qianyi Luo, … Ashay Dilip Bhatwadekar·bioRxiv·Jul 30, 2025
- APOE4 expression confers a mild, persistent reduction in neurovascular function in the visual cortex and hippocampus of awake mice
Orla Bonnar, Kira Shaw, … Catherine N. Hall·Journal of Cerebral Blood Flow & MetabolismPeer-reviewed·Jun 23, 2023
- Microglia Depletion Reduces Human Neuronal APOE4-Driven Pathologies in a Chimeric Alzheimer's Disease Model
Antara T. Rao, Nuo Chen, … Yadong Huang·bioRxiv·Nov 10, 2023
- APOE 4/4 promotes dysfunctional and inflammatory phenotypes concomitant with impaired maturation of hiPSC-derived astrocytes
Rebeca Vecino, Eva Díaz‐Guerra, … Carlos Vicario‐Abejón·bioRxiv·Sep 10, 2026